Katsunori Shinozaki

4PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 25, 2025
Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1-Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study.

Kohei Shitara, Motohiro Tamiya, Kyoichi Okishio

|Mar 25, 2025
A phase 2 study of adjuvant chemotherapy with 5-fluorouracil/leucovorin and oxaliplatin after lung metastasectomy for colorectal cancer (WJOG5810G).

Nozomu Machida, Takehiro Okumura, Narikazu Boku

|Feb 13, 2025
BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS).

Hiroya Taniguchi, Kay Uehara, Toshiaki Ishikawa

|Oct 24, 2020
A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI).

Katsunori Shinozaki, Takeshi Yamada, Junichiro Nasu

Pageof 1

Frequent Collaborators

2 joint publications

Hiroyuki Okuda

2 joint publications

Toshifumi Yamaguchi

2 joint publications

Tomohiro Nishina

1 joint publications

Hiroya Taniguchi